IndiaRF begins stake sale process in Synthimed Labs, appoints Rothschild & Co
India Resurgence Fund has appointed Rothschild to sell a minority stake in API and CRAMS firm Synthimed Labs, seeking a $1 billion valuation a little over two years after acquiring the asset.
India Resurgence Fund has appointed Rothschild to sell a minority stake in API and CRAMS firm Synthimed Labs, seeking a $1 billion valuation a little over two years after acquiring the asset.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
